openPR Logo
Press release

Peptide Based Hematological Disorders Therapeutics Market Expected to Secure Notable Revenue Share during 2017-2022

12-10-2018 10:45 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Due to the advances in technology, the manufacturers and suppliers are encouraged to seek novel methods for peptide manufacturing, which is bound to improve the production of longer and complex chain of peptides and reduce the cost of production. Moreover, due to the automation of instruments, with improvements in the purification process and reduction in the total waste generated, are the driving factors triggering the growth of the global peptide therapeutics market. However, the synthesis and purification of long peptides is challenging for the manufacturers. Also, the rise in modifications and the addition of more unnatural amino acids have further increased the complications in peptide synthesis. This makes the manufactures of peptides difficult, and therefore the gap between demand and supply is increasing. Also, the manufacturing of peptides is a costly process, which hampers the growth of the global peptide therapeutics market.

Get Free Sample Report here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=189

Haematological disorders are the disorders related to problems in blood and blood components such as red blood cells, white blood cells, platelets, blood vessels, lymph nodes, spleen, bone marrow and the problems related to the proteins involved in bleeding and clotting (haemostasis and thrombosis). Therapeutic peptides are used in the treatment of haematological disorders mentioned above. Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. Such type of covalent chemical bonds are formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are differentiated from proteins on the basis of size, and peptides contain 50 amino acids or less approximately. 

This Fact.MR report on the global peptide based hematological disorders therapeutics market forecasts that the global peptide based hematological disorders therapeutics market will touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

4 Forecast Highlights on Global Peptide Based Hematological Disorders Therapeutics Market

As per the forecast of Fact.MR, the ecallantide segment is slated to touch a value of nearly US$ 120 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The ecallantide segment is estimated to account for more than one-fifth of the revenue share of the drug segment by the year 2017 end and is expected to gain in market share by the year 2022 end.

As per the forecast of Fact.MR, the retail pharmacies segment will reach a value of nearly US$ 115 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The retail pharmacies segment is estimated to account for more than one-third of the revenue share of the distribution channel segment in the year 2017 end and is expected to gain market share by the end of the year 2022.  

As per the forecast of Fact.MR, by the end of 2022, North America peptide based hematological disorders therapeutics market is projected to reach nearly US$ 220 Mn, registering a robust CAGR over the forecast period.

As perFact.MR forecasts, the US peptide based hematological disorders therapeutics market is estimated to account for 88.6% revenue share of the global peptide based hematological disorders therapeutics market by 2017 end and is expected to gain in market share by 2022 over 2017.

Know the methodology behind the report @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=189

Icatibant Segment Poised to Touch a Value of Nearly US$ 410 Mn in 2022

As per the forecast of Fact.MR, the icatibant segment is expected to reach a value of nearly US$ 410 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Icatibant segment is expected to account for more than three-fourth of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.  

Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period

As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 260 Mn in the year 2022. This represents a CAGR of 7.4% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global peptide based hematological disorders therapeutics market through 2022, which includes Shire plc.

Grow Your Business From Expert Advice @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=189

Table of Content:

Global Peptide Based Hematological Disorders Therapeutics Market - Executive Summary
Global Peptide Based Hematological Disorders Therapeutics Market Overview
2.1. Introduction
     2.1.1. Global Peptide Based Hematological Disorders Therapeutics Market Taxonomy
     2.1.2. Global Peptide Based Hematological Disorders Therapeutics Market Definition
2.2. Global Peptide Based Hematological Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Peptide Based Hematological Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Hematological Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Drug 
3.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
     3.1.1. Icatibant Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
              3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Ecallantide Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Distribution Channel 
4.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
     4.1.1. Hospital Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
              4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Retail Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
Continued……………..

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide Based Hematological Disorders Therapeutics Market Expected to Secure Notable Revenue Share during 2017-2022 here

News-ID: 1428026 • Views: 121

More Releases from Fact.MR

Isocyanates Manufacturers Leveraging Advancements and Modernization in the Adhes …
The recently published report by Fact.MR regarding the global isocyanates market includes product classification and current synopsis along with product upgrades and innovations. Increasing demand from the building and automotive industries is increasing the polyurethane consumption in numerous consumer and industrial applications. Moreover, the thriving pharmaceutical industries, and isocyanates advantageous characteristics are the primary drivers for development in the worldwide isocyanate market. Burgeoning isocyanate acceptance for use in newer vertical
Increasing Commuter Preference for Shared Taxi Will Boost the Demand for Minibus …
Global value for the minibus market reached ~ US$ 8.3 Bn in 2018, as disclosed by the new research study by Fact.MR. According to the report, the minibus market is predicted to grow by CAGR of ~3.7% in the forecast period, primarily influenced by prominent players investing in manufacturing operations in the global minibus market landscape. According to the research, an increasing center of attention on new developments and the demand
Ergonomic Designs of Furniture and a Favourable Policy Framework for Newer Entra …
The global office furniture market is expected to create ~ US$ 22 Billion worth of incremental opportunity over the forecast period. Since the last two decades, the number of small, micro, and medium-sized enterprises has increased drastically in developed and developing countries. Moreover, constant provision from private investments and governments is fueling the growth of the private sector, which is further propelling the office furniture market growth to a great
Cyclopentane Market Statistics Based on Upcoming Chemical Industry Trends and Su …
The adoption of cyclopentane in commercial refrigerators has opened up new opportunities for the global cyclopentane market. Cyclopentane is popularly used as a foam blowing agent for polyurethane foams that are used to insulate freezers and refrigerators. The commercial refrigerator sector is experiencing a healthy growth across the globe, with Asia pacific region as the fastest growing region. The importance of commercial refrigerators is also increasing due to fluctuating climatic

All 5 Releases


More Releases for Peptide

Peptide Therapeutics Market | Forecast up to 2024
Global Peptide Therapeutics Market: Overview This report provides in-depth region wise and country wise analysis of the peptide therapeutics market. Stakeholders of this report include manufacturers of peptide products, raw material suppliers, nutraceutical and cosmeceutical companies, food processing industries and new players planning to enter the market. It further provides qualitative and quantitative analysis of the global peptide therapeutics market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market
Peptide Vaccine Market Peptide Vaccine Clinical Pipeline Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Peptide Vaccine: A Prologue to Sub-Unit Vaccines 1.1 Introduction 1.2 Glimpse of Antiquity 2. Need of Peptide Vaccines 2.1 Why Peptides – More Desirable 2.2 Peptide Vaccines V/S Traditional Vaccines 3. Classification of Peptide Vaccines 3.1 On the Basis of Sources Obtained 3.2 On the Basis of Length 3.3 On the Basis of
Global Natriuretic Peptide Market Research Report 2017
Report Hive Market Research Released a New Research Report of 107 pages on Title " Global Natriuretic Peptide Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Natriuretic Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented
Global Peptide Therapeutics Pipeline Insight 2015
Peptides are small molecules of varying molecular masses that consist of amino acids joined with the help of peptide bonds (CONH2). One end of the molecule consists of carboxyl (COOH2) group while the other end has amino (NH2) group giving rise to polarity. Biologically, they are very important and found to play an important role in various anabolic and catabolic processes. They are essential component of cell signaling pathways, immune
Global Peptide Vaccine Market & Pipeline Insight
Peptide vaccines are peptides that exhibit pharmacological properties by activating human immune system rather than showing pharmacologically activity by themselves. They are administered into body to enter in lymph nodes where they induce long lasting immune response. They utilize immune system and develop long term acquired immunity which has capability to prevent future incidences of pathogen attack. Every living cell in human body has surface markers as an instrument to
Animal Antibacterial Peptide 2024 Market Research Report
Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and